Wikipedia

User:Madhero88/Essential hypertension ref

< User:Madhero88

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]





















  1. ^ Hall JE (March 2003). "The kidney, hypertension, and obesity". Hypertension. 41 (3 Pt 2): 625–33. doi:10.1161/01.HYP.0000052314.95497.78. PMID 12623970. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  2. ^ Wofford MR, Hall JE (2004). "Pathophysiology and treatment of obesity hypertension". Curr. Pharm. Des. 10 (29): 3621–37. doi:10.2174/1381612043382855. PMID 15579059. Retrieved 2009-06-07.
  3. ^ Davy KP, Hall JE (May 2004). "Obesity and hypertension: two epidemics or one?". Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (5): R803–13. doi:10.1152/ajpregu.00707.2003. PMID 15068965. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  4. ^ Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J (October 2003). "Impact of the obesity epidemic on hypertension and renal disease". Curr. Hypertens. Rep. 5 (5): 386–92. doi:10.1007/s11906-003-0084-z. PMID 12948431.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  5. ^ Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L (March 2003). "Obesity-associated hypertension and kidney disease". Curr. Opin. Nephrol. Hypertens. 12 (2): 195–200. doi:10.1097/01.mnh.0000058795.51455.3f (inactive 2023-08-02). PMID 12589181. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: DOI inactive as of August 2023 (link) CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  6. ^ Hall JE (April 2000). "Pathophysiology of obesity hypertension". Curr. Hypertens. Rep. 2 (2): 139–47. doi:10.1007/s11906-000-0073-4. PMID 10981140.{{cite journal}}: CS1 maint: date and year (link)
  7. ^ Brands MW, Hall JE, Keen HL (January 1998). "Is insulin resistance linked to hypertension?". Clin. Exp. Pharmacol. Physiol. 25 (1): 70–6. doi:10.1111/j.1440-1681.1998.tb02148.x. PMID 9493563.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  8. ^ Hall JE, Summers RL, Brands MW, Keen H, Alonso-Galicia M (August 1994). "Resistance to metabolic actions of insulin and its role in hypertension". Am. J. Hypertens. 7 (8): 772–88. doi:10.1093/ajh/7.8.772. PMID 7986471.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  9. ^ Hall JE, Brands MW, Zappe DH, Alonso Galicia M (April 1995). "Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations?". Proc. Soc. Exp. Biol. Med. 208 (4): 317–29. doi:10.3181/00379727-208-43862B. PMID 7700881.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  10. ^ Hall JE, Granger JP, Hester RL, Montani JP (October 1986). "Mechanisms of sodium balance in hypertension: role of pressure natriuresis". J Hypertens Suppl. 4 (4): S57–65. PMID 3021942.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  11. ^ Vargas Alarcón G (2006). "[Physiopathogenesis of hypertension]". Arch Cardiol Mex (in Spanish; Castilian). 76 (Suppl 2): S157–60. PMID 17017092.{{cite journal}}: CS1 maint: unrecognized language (link)
  12. ^ Naber CK, Siffert W (October 2004). "Genetics of human arterial hypertension". Minerva Med. 95 (5): 347–56. PMID 15467511. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  13. ^ Hermann M, Flammer A, Lüscher TF (December 2006). "Nitric oxide in hypertension". J Clin Hypertens (Greenwich). 8 (12 Suppl 4): 17–29. doi:10.1111/j.1524-6175.2006.06032.x. PMID 17170603. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  14. ^ Pośnik-Urbańska A, Kawecka-Jaszcz K (2006). "[Hypertension in postmenopausal women --selected pathomechanisms]". Prz. Lek. (in Polish). 63 (12): 1313–7. PMID 17642147.
  15. ^ Harrison-Bernard LM, Raij L (April 2000). "Postmenopausal hypertension". Curr. Hypertens. Rep. 2 (2): 202–7. doi:10.1007/s11906-000-0083-2. PMID 10981150.{{cite journal}}: CS1 maint: date and year (link)
  16. ^ Masszi G (December 2002). "[Hypertension and menopause]". Orv Hetil (in Hungarian). 143 (51): 2821–8. PMID 12638308.{{cite journal}}: CS1 maint: date and year (link)
  17. ^ Oparil S, Zaman MA, Calhoun DA (November 2003). "Pathogenesis of hypertension". Ann. Intern. Med. 139 (9): 761–76. doi:10.7326/0003-4819-139-9-200311040-00011. PMID 14597461.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  18. ^ Muratani H, Fukiyama K (April 1992). "[Pathogenesis of essential hypertension--a perspective]". Nippon Rinsho (in Japanese). 50 Suppl: 250–6. PMID 1635200.{{cite journal}}: CS1 maint: date and year (link)
  19. ^ Rossier BC (April 2003). "Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension?". J. Clin. Invest. 111 (7): 947–50. doi:10.1172/JCI18232. PMC 152592. PMID 12671041. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  20. ^ Katori M, Majima M (2006). "A missing link between a high salt intake and blood pressure increase". J. Pharmacol. Sci. 100 (5): 370–90. doi:10.1254/jphs.CRJ06003X. PMID 16651701. Retrieved 2009-06-07.
  21. ^ Reckelhoff JF (May 2001). "Gender differences in the regulation of blood pressure". Hypertension. 37 (5): 1199–208. doi:10.1161/01.HYP.37.5.1199. PMID 11358929. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  22. ^ O'Shaughnessy KM, Karet FE (April 2004). "Salt handling and hypertension". J. Clin. Invest. 113 (8): 1075–81. doi:10.1172/JCI21560. PMC 385413. PMID 15085183. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  23. ^ Carretero OA, Oparil S (January 2000). "Essential hypertension. Part I: definition and etiology". Circulation. 101 (3): 329–35. doi:10.1161/01.CIR.101.3.329. PMID 10645931. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link)
  24. ^ Lifton RP, Gharavi AG, Geller DS (February 2001). "Molecular mechanisms of human hypertension". Cell. 104 (4): 545–56. doi:10.1016/S0092-8674(01)00241-0. PMID 11239411. Retrieved 2009-06-07.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  25. ^ Bähr V, Oelkers W, Diederich S (April 2003). "[Monogenic hypertension]". Med. Klin. (Munich) (in German). 98 (4): 208–17. doi:10.1007/s00063-003-1245-1. PMID 12715144.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  26. ^ Toka HR, Luft FC (March 2002). "Monogenic forms of human hypertension". Semin. Nephrol. 22 (2): 81–8. doi:10.1053/snep.2002.30206. PMID 11891501.{{cite journal}}: CS1 maint: date and year (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Madhero88/Essential_hypertension_ref&oldid=1168388666"